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Osaka, Japan; Burlington, Framingham and Buster, Massachusetts; and Bethesdu. Maryland 
O&diver. ibis study sought to etine clinical determinants 
of heart rate variability and to report normative reference values 
for eight heart rate variability measures. 
Backg~&. Although the clinical implications of heart rate 
variability bave been described, clinical determinants and norma- 
tive values of heart rate variability measures bare not been 
studied systematically in a large community-based population. 
hfcthafs. llse lirst 2 II of ambulatory eMrocardiographic 
mcordiqs obtained in Framingham Heart Study subjects attend- 
ing a routine examination were repmcessed for beart rate vari- 
ability. Recordings with !ransient or persistent nonsinus rhythm, 
premah~ beats >I@% of total beats, <l-h reconfinp time or 
processed time <SO% of recorded time were exchnl@ subjects 
receiving autian-hythmic medications also were excluded. Among 
five tkequeuq domain and three time domain measures that were 
obtaii@ low fkquenq tmwer (0.04 to 0.15 Hz), high fmqueacy 
pomr (0.15 to 0.40 Hz) and the standard deviation of total normal 
RR intervals hased on 2-h recordiqgs w:re selected for the 
principal analyscs. Variables with potential physiologic eEect.5 or 
possible technical influences on heart rate variability measures 
were chosen for multiple linear regression analysis. Normative 
Reduced beat to beat variability in RR intervals, commonly 
referred to as heart rate variability, is observed in patients with 
congestive heart failure (I), coronary heart disease (2,3) and 
diabetic neuropathy (4-6). Various physiologic factors also 
affect heart rate variability, including aging (7), postural 
changes (8) and time of day (9). Although prognostic (10-15) 
and other clinical implications (16-21) of altered heart rate 
variability have been described, the clinical determinants of 
heart rate variability have not been studied systematically. Few 
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values, derived from a subset of healthy subjects, were adjusted 
for age and heart rate. 
Rcsu&r. There were 2,722 eliible subjects with a mean age 
(*SD) of 55 f 14 years. Tbm separate multiple linear regression 
anulyses revealed that higher heart rate, older age, beta- 
adrenergic Mocking agent use, history of myocardial infarction or 
congestive heart failure, diuretic use, diastolic blood pressure 
290 mm Rg, diabetes mellitus, consumption of three or more 
cups of co& per day and smoking were associated with lower 
values of one or more heart mte variability measures, whereas 
longer processed tims start time in tbe nrornin& frequent su- 
praventricular and ventticular premature beats, female Render 
and systolic blood pressure Z160 mm Hg were associated with 
higher values. Age and heart rate were the major determinants of 
all three selected heart rate variability measures (partial R’ 
vahws 0.125 to 0.389). Normative reference values for all eight 
heart rate variability measures are presented. 
CcAu&n.r. Age and heart rate must be taken into account 
when assessing heart rate variability. 
(J Am Cdl G&id 1996;.!8:1539-46) 
previous studies have reported normative reference values for 
heart rate variability measures (22-24). 
The objectives of the present study were to assess clinical 
determinants cf heart rate variability and to provide normative 
values for several heart rate variability measures as a function 
of age and heart rate. This investigation was performed in a 
large population-based sample in which referral bias was 
inherently minimal. 
Methods 
Study sample. In 1948, 5.209 residents of Framingham. 
Massachusetts, who were between the ages of 28 and 62 years, 
were sekcttd to undergo biennial examinations in a prospec- 
tive epidemiologic study. In 1971, 5.124 additional subjects 
(offspring of the o:iginal cohort and spouses of these offspring) 
entered a’ similar prospective study. Selection criteria and study 
design have been previously reported (25.26). From 1983 to 
1987; ambulatory electrocardiograph‘ic (ECG) recording were 
obtained in surviving study subjects attending a routine. sched- 
uled examination. 
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Abbreviations avd Acronyms 
ECG 
r. 
= elcctrcr;irdiographiu 
LF;‘HF = low frcqucnr):high frqutncy pwcr r& 
PNN.ill 7 pcrcsntiigc of~diffcrcnccb twwecn 3djacsnf normal 
RR inwrulr :-XI mh 
I 
I -MSSD = quart r&t cri the mean of the .qunrrd dikwscsr 
bct\rccn zdi.1 :mt normal RR intr‘rvals 
L- 
SDNS = standard dw.&m nf nnnnal RR intcruls 
messing of ambulatory recordings. The first 2 h of 
ambulatory recordings were processed for heart rate variability 
using a Cardiodata/Mortara Mk5 Holter analysis system. ‘i-h 
tape speed w;is 1 mm/s, and one channel was used to record a 
32-Hz crystal-controlled timing track. For heart rate variability 
analysis. tapes were played back at 120 times real time on a 
Cardiodata/Mortara Mk5 Holter analysis system (Mortara 
Instrument Co.) that sampled each KG channel at 180 
samplesb. The playback incorporated a phase-locked loop 
using the recorded timing track to compensate for errors in 
recorder speed contra!. Peat to beat RR interval data were 
obtained from the “beat stream file.” A linearly interpolated 
beat was substituted for intervals of ectopic beats or artifact 
less than or equal to two RR intervals (27). The fast Fourier 
transform was calculated on 100-s blocks of RR interval data. 
A continuous curve was formed by linear interpolation be- 
twecn RR intervals; this was subjected to a Hamming window 
and resampled at 1.28 times/s. If there was a run of arrhythmia 
or artifact >l beat long, the 100-s block was terminated, the 
partial block was discarded, and a new block was started at the 
end of the unusable period. Power density spectrum was 
estimated by taking the sum of the squares of the magnitude of 
the fast Fourier transform performed on all usable 100-s blocks 
(271. The resulting 100-s power spectra were corrected for 
attenuation resulting from sampling and the Hamming window 
and were averaged. Akhough the resulting frequency range of 
the power spectra was 0.01 to 0.64 Hz, we restricted our 
analyses to frequencies ~0.40 Hz to maintain comparability of 
the high frequency component of our data with prev:ous 
reports (11,12). The 100-s method was intended to avoid any 
assumptions about sinus node activity in consecutive arrhyth- 
mias in which sinus node activity was unknown. When longer 
time blocks are used, larger amounts of data are discarded 
because of consecutive premature beats or artifact. In contrast, 
when shorter time blocks are used, the minimal frequency for 
which the power spectrum can be measured is >O.Ol Hz. We 
computed the 2-h power spectral density and calculated five 
frequency domain measures: 1) very low frequency power (O.Oi 
to 0.04 Hz); 2) low frequency power (0.04 to 0.15 Hz); 3) high 
frequency power (0.15 to 0.40 Hz); 4) total power (0.01 to 
0.40 Hz); +d 5) the ratio of low frequency to sigh frequency 
power (LF/HF). In addition, we computed three time domain 
measures: 1) standard deviation of normal RR intervals 
(SDNN); 2) the percentage of differences between adjacent 
normal RR intervals >50 ms (pNN50); and 3) the square root 
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of the mean of th? squared differences betwetin adjacent 
normal ,RR intervals (r-MSSD). Time domain variables’were 
calculated from the lUO-s segments used to calculate’ the 
frequency domain variables. Because SDNN theoretically in- 
creases as a function of recording time. the lrrm 2-h SDNN is 
used hereafter. 
We selected high and low frequency pov+cr as frequency 
domain measures for further analyses because rhe physiologic 
meaning of high frequemy power has been delineated (28). 
and low frequency power was prrdictivs of prognosis in the 
elderly population of the Framingham Heart Study (13). Also. 
both measures are compatible with those of previous reports 
and are not dependent on the 100-s block method (29). In 
addition to these two measures, 2-h SDNN was selected 
because it is conceptually a simpler measure of heart rate 
variability. 
Normal QRS complexes and arrhytl.mias were diagnosed 
under constant visual monitoring. Supraventricular premature 
beats were differentiated from sinus arrhythmia on the basis of 
P wave configuration and cyclic changes in RR intervals. For a 
tape to be eligible for this study. we required that it have 
~60 min of analyzable data (11.12), at least 50% time pro- 
cessed and premature beats < 10% of total beats (30). 
Clinical covariates. Risk factors possibly predisposing to 
coronary heart disease were recorded at each examination 
(25). Variables that might be associated with autonomic func- 
tion were also considered, including coffee and al:ohol con- 
sumption, current cigarette smoking and use of cardioactive 
medications. Average reported alcohol consumption was con- 
verted to ounces of alcohol/week assuming that a 12-0~ bottle 
or can oE beer had 0.44 oz of alcohol, a glass oi wine 0.40 oz 
and a measure of spirits 0.57 oz (31). 
Systolic and diastolic blood pressures were obtained twice 
in the seated position by the examining physician using a 
mercury column sphygmomanomeicr positioned near eye 
level. The average of the two readings was used for each blood 
pressure variable. Diuberes was defined on the basis of a 
nonfasting blood glucose level 2200 mg/dl (11.10 mmollliter) 
or the use of insulin or an oral hypoglycemic agent. Heart rate 
was calculated as the mean value obtained on the same 
ambulatory monitoring recording that was processed for heart 
rate variability. The number of ventricular premature beats/ 
hour was analyzed as a continuous variable, but supraventric- 
ular premature beats were recoded into three groups as 
fellows: <120/h, 120 to 240/h and >24O/h. 
The Framingham definitions of myocardial infarction and 
congestive heart failure have been described elsewhere (32). 
At each follow-up examination, interim cardiovascular events 
were essed with the help. of medical, history, physical 
examination and the 1Zlead ECG., In addition, medical 
records were obtained for participants who did not attend an 
examination, and these were evaluated for evidence of interim 
heart disease. All suipected interim events were reviewed by a 
committee of three physicians who evaluated pertinent medi- 
cal records, hospital records and pathology reports. 
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Table 1. Pratwn Correlations .1mong Measures of Heart Rate \‘ariahi!ity’ 
- 
In 
In In In In LF, HF In 2-h In In 
VLF+ LF HF TPt R&l SDNN pSNW r-MSSD 
Mean 7.37 h.U 5.3 I 7.3' I- I.12 4.41 I .50 3. !fl 
SD 
In VLFt 
in LF 
In HF 
In TPt 
In LFlHF ruin 
In l-h SDNN 
In pNNS0 
0.7.l 0.00 (I.‘:3 o.xl l1.51 0.31 IX I I.41 
0.M 0.7ll I l.(ti II.:? Il.dU N’ll Il.hs 
IuiJ NYC ll.I!* ON (I.73 0.71 
11.55 - II.32 0.7.5 O.Vl 11.43 
Il.11 il.SY 11.7' (I.iS 
(l.U7 -0.3 -- NJI 
11.70 MY 
11.93 
Statistical methods. Measures of heart rate variability 
were natural log transformed because their distributions were 
highly skewed. Associations among transformed variables were 
assessed with Pearson’s correlation coefficients. In preliminary 
analyses, mean values of heart rate variability measures were 
plotted against age (grouped in l@year intervals) and heart 
rate (grouped in IO-heatlmin intervals) to verify that the 
relations were linear with constant variance. 
The principal analyses consisted of three forward stepwise 
multiple linear regression procedures (33) to select variables 
reiated tn heart rate variability (i.e., In 2-h SDNN. In low 
frequency power, In high frequency power) from among 16 
candidate variables: age, gender. heart rate, starting time of 
moritoring (AM or PM), total processed time (SW vs. 
BY0 min), systolic (<16Ovs. 2160 mm Hg) and diastolic (<YO 
~3. rY0 mm Hg) blood pressure, number of ventricular pre- 
mature beats/h, number of supraventricular premature beats/h 
(cl20 vs. 124l to 240 vs. >240), history of myocardial infarction 
or congestive heart failure (no vs. yes), presence of diabetes 
mellitus (no vs. yes), use of beta-adrenergic blocking agents 
(no vs. yes), use of diuretic drugs (no vs. yes), smoking (no vs. 
yes), coffee consumption (0 vs. 1 to 2 vs. r3 cups/day) and 
alcohol intake (0 vs. 1 to 2 vs. r3 ozhveek). These variables 
were chosen because of their potential physiologic effects on 
measures nf heart rate variability or because of a possit;le 
technical influence on the measurement. The Statistical Anal- 
ysis System procedure REG (34) was used, and each categoric 
variable was encoded by dummy indicators that were entered 
or removed as a group. Whereas it is common to define 
statistical significance with a Type I error rate of alpha 0.05, we 
adopted a more stringent alpha 0.001 for testing multiple 
variables across three outcomes; furthermore, we dtfined an 
“important” variable as onk that contributed a.‘partial R’ 
statistic ZO.005. 
Normative values of heart rate variability were generated 
from a subset of subjects who were free of coronary heart 
disease, cerebrovascular disease, congestive heart failure and 
diabetes mellitus and who were not receiving cardioactive 
medications. We further restricted this reference sample to 
subjects 20 to 79 years old with heart rates between 40 and 
99 beatslmin. Linear regression was used with the log- 
transformed data to account for age and heart rate. Estimates 
were made of the 5th. 25th and 50th percentile values by 
applying normal theory to the natural log-transformed data 
before transforming back to the origin;;1 units. 
Results 
Of the 10,333 original and offspring Framingham Heart 
Study subjects, 5.698 attended the index examination. There 
were 2,278 (40%) subjects in whom ambulatory recordings 
were not obtained. Ambulatory ECGs were obtained from 
June lYS3 to September 1967. Subjects who attended corre- 
sponding examinations, but who did not have ambulatory 
ECGs, spanned a similar period (April 1983 to June 1987). 
Some basic statistics on subjects who had (vs. those who did 
not have) ambulatory ECG recordings are as follows: .SZ (vs. 
55%) women. mean age 56 (vs. 5X) years. age range 21 to 93 
(vs. 18 to 94) years, mean systolic/diastolic blood pressure 
129/78 (vs. l30/78) mm Hg. Thus. the two groups were 
comparable; ,there was no evidence of selection bias. Among 
3.420 subjects with tapes analyzed, 698 were excluded from 
analysis. mostly due to excessive artifact (n = 500). Compared 
with excluded subjects (n = 698), those’who were analyzed 
were .younger (age 55 vs. 62 years. analyzed vs. excluded) but 
had the same gender distribution (55% vs. 53% female) and 
had similar blood pressure (129/78 vs. 133/?8 mm Hg) and 
mean heart rate (73 vs.‘74 beatslmin). The mean age of the 
2,722 eligible subjects was 55 years (range 21 to 93), and 1.236 
(45%) were men. The mean heart rate ‘(2 SD) was 73 + 1 I 
beats/min. A history of myocardial infarction was present in 
107 subjects (4%) and congestive heart failure in I7 (1%); 
diabetes was present in 127 subjects (5%). 
. . 
N 
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Table 3. Regression CocUicients and Partial R’ Values of Clinica! Variah!ss R&ted tn Heart Rate 
Variahilitv Mcasurcs*i 
-- 
In 2-h SDNS In LF In HF 
-- --.- 
Viiriahle CO& Partial I?’ CL-d Partial R‘ cwff Partial R-’ 
- 
Age 110 yr) il.1 I il21S .-1l.3h 03SY -11.33 Il.22 
HR (.Itl bcatvmin) .-II. I7 (l.“h -- -- Il.33 n.13 --0.3~ t1.152 
Beta-bluctcr uw --O.I? ll.01’) !I.35 11SlN -4.14 (ISlo 
Pruccsud time :+tI riin NIK 11.1113 SS ES $ 
Diuretic use § --(I.3 o.lYw $ 
History of MI nr CHF B -U.4! nm - 0 
smoking 4 U.!S 0.007 0 
SVPBS 1 ?I&-~40,ll t t Oh? 
SVPBS >?4Oh + $:I t &I (I.87 :1.027_1: 
Female gender t $ - $ Il.:;1 ~~.ull 
Listed m&l (nu. of terms R-‘) 4 (I.!75 h 0.55X h NJ:3 
Final mudcl (no. of terms. R’) I4 II.LIII 13 II.Zi’ . - Ih !1..m 
‘0nly lkse clinical vari;lhla rxmtnhutinfi pafli4 R’ XJ.WS to one or more heti rate vkhility mcaurcz are included 
here; wknevcr the partial tJ.’ excccdcd O.(N)5, tbc nxresponding p value was <0.OtlO1. I’Otbcr clinical variabks ;~EvL.iatrY with 
beart rdte variability measures to B lesser eticnt were U f&h (a minu\ sign indicates invcrsc auxiation rhcrc* dirryt 
assnciatiun is the default): fur bt 2-h SDNN, thcrc were VPIkh (p < 0.001). nn!ming start time (p x tNltl1) and -dirtiulk 
hluud ppgsurc ~90 mm Hg (p < 0.05): for In LF puwer. tbcrc wcx VP&h (p i (l.Oll1). -diaktc+ (p < I).lLl1). - diastdlc 
blaxi pressure ~90 mm Hg (p < 0.05) and morning start timr (p i O.(6): ;tnd fur In HF pmvcr. there wcrc VPbh (p .: (I.(~!1 ). 
-diasrdic blood prewre HU mm Hg (p < 0.0111). systolic hluud prc%,ure 2 lb0 mm Hg (p < O.OS) and -coffee omsumplbm 
(p .z 0.05). Only akobol amsumption wiLv, not associated. 81 p < O.M. uitb my of the thnx beart rate variability measures. 
tVariable was marginally significant with O.OOl c- p < 0.05, but partial R’ was <O.OOS. ~Variahic *as significant with p <: O.tWl. 
but partial Rz was ~0.005. 11Partkal R’ for SVPBs &monstrdted amtributium fmm all three categkcs: ~:lZOh. 1% to ?4l!h. 
>2Ql1. NS = variable was not signiticant (p z 0.M) in the stepvis model. - nr + = tign of rrpskn caxfficicnt (cxr8) in 
tbe final model: other abbrcviatkns as in Tables I and ?. 
effect of a IO-year age difference equaled the effect of a 7- to 
1 I-beatlmin heart rate difference. 
Normative vahcs of heart rate variability measures. A 
hubset of 1,918 subjects (mean [? SD] age 50 + 13 years. range 
20 to 79 years: 865 [45%] men; heart rate 40 to 99 beats/min) 
were studied to assess heart rate variability in a healthy 
reference sample. These subjects were without clinically ap- 
parent heart disease and were not receiving cardioactive 
Fii 1. Fitted regression lines of 2-h SDNN as a function of age and Fire 2. Fitted regression lines of low frequenty (LF) power as a 
heart rate for entire study sample. Data are shown for five specific ages function of age and heart rate for entire study sample. Data are shown 
(35,45.55,6.5 and 75 years) at mean heart rates between 50 and Ifi) for five spLrific ages (3s. 45. 55, 65 and 75 years) at mean heart rates 
beatslmin. ktween SO and 100 katslmin. 
medications. Percentile values for all hcdlt rdtr: vanability 
measures were estimated by combining rcgrcssion techniques 
and normal statistics theory: these are shown in Table 4 for 
three age groups and three heart rate categories. Note that as 
age or heart rate increases. heart rate variability decreases- 
the bottom 5th percentile limit is smaller at age 70 than at age 
30. Agreement between these estimated pcrcentilcs and em- 
piric data was excellent. 
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Discussion 
To our knowledge, this is the first report to quaniitatc the 
.contributibns of several’ determinants of heart rate variability 
in a large. community-hascd sample. Mean heart rate and age 
were the major determinants. together accounting for 37% to 
5 1 <i- of the variance of 2-h SDNN and !ow and high frequency 
power. These results confirm and supplement previous reports 
(7.22:35,3(j) tttlt associated age and heart rate with heart rate 
variability. 
Major determinants of heart rate variability. Heart rate 
was inversely associated with all eight measures of heart rate 
variability; this was true for all age strata and in both men and 
women. Heart rate accounted for 12.5% to ‘22.6% of the 
variance in 2-h SDNN and low and high frequency power. The 
role of heart rate should be considered when assessing inter- 
ventions that affect heart mtc. such as beta-blocker use (37) or 
exercise (38). 
Consistent with previous reports (7.22.39), age was another 
major determinant of heart rate variability. accounting for 
21.8% to 38.9% of the variance in 2-h SDNN and low and high 
frequency power. The impact of a IO-year increment in age was 
roughly that of a IO-beatlmin increment in heart rate. 
Other determinants of heart rate variability. After adjust- 
ment for heart rate and other covariates, beta-blocker use was 
significantly associated with reduced heart rate variability: it 
accounted for 1 Q to 2% of the observed variance. The impact 
of beta-blocker use was similar to that observed for a l&beat/ 
min increase in heart rate. Our data suggest, however, that if 
beta-blockers reduce heart rate by ~10 beats/min, their use 
will result in a net increase in heart rate variability. 
The effect of duration of recording on frequency domain 
measures has been reported by Bigger et al. (40). In their 
results, the heart rate variability values of 8-h daytime record- 
ing, compu!ed from various short segments, were not mean- 
ingfully different from mean values obtained from a full 24-h 
period. In our 2-h analyses, duration of recording time had an 
association with high frequency power, but its contribution was 
very small, and no association was found with low frequency 
power. These data suggest that duration of recording contrib- 
utes minimally to frequency domain measures of heart rate 
variability. in contrast, our data document that SDNN is 
affected by processed time: the longer the recording, the 
greater the fluctuations in heart rate and the larger the value of 
SDNN. The duration of available data should be considered in 
the interpretation of SDNN. 
Diuretic use and smoking were associated with lower heart 
rate variability. Cigarette smoking has been reported (41) to 
reuuce high frequency power. These associations might be due 
to biologic effects of diuretic drugs and cigarette smoking. It is 
a!+> possible that left ventricular hypertrophy (42) or subclin- 
ical coronary artery disease confound these associations, 
The presence of supraventricular and ventricular premature 
beats a&ted heart rate variability measures. To minimize the 
effect of premature complexes, we excluded subjects with 
premature beats >lO% of total beats (30). Nevertheless, 
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CizurP 3. Fitted rrgrcssion lines of high frrqucncy (HF) purr 6s a 
function d age and heart rate for entire study sar,;plc. Data arc shown 
for five specitic ages (X,45,55.65 and 75 years) at mean heart rates 
hctwcrn SO and 100 heats’min. 
irequent supraventricular premature bez t!, substantially af- 
fected heart rate variability mtiasures. T x: impact of single 
supraventricular premature beats was miriinized by use of an 
interpolated correction methd. Con-c&e premature beatc 
did not affect heart rate variability: wtcn such arrhythmias 
occurred, the corresponding 100-s blocks mere terminated and 
discarded. It is possible that the nonunilbrmity of compensa- 
tory pauses after ventricular prematmir beats resulted in 
imprecise interpolation of sinus node activity. 
Heart raie variability has been reportea (5) to be reduced in 
patients with diabetic neuropathy, but not in the presence of 
uncomplicated diabetes. In our study, diabetes was associated 
with reduced low frequency power, but not with high frequency 
power or SDNN The lack of association of diabetes with high 
frequency power or SDNN may have been due to the small 
number of subjects with diabetes (n = 127), few of whom had 
diabetic neuropathy. 
Minor differences in one or more heart rate variability 
measures were observed for gender, time of day of recording 
and presence of frequent ventricular premature beats. 
Comparison with previous studies. A recent study by Big- 
ger et al. (23) reported reference values for a variety of heart 
rate variability measures in 202 men and 72 women (40 to 69 
years old, mean age 57; mean heart rate 73 heats/min). Mean 
values in that report were similar to those observed in our 
sample with a mean age of 55 years and a mean heart rate of 
73 beatslmin, except for total power and SDNN. The discrep- 
ancy in total power is explained by a different sampling 
method, whereas differences in SDNN are explained by the 
shorter duration of recordings in our sample. Smaller differ- 
ences observed in high frequency power, LF/HF ratio and 
pNNS0 may he due to, differences in sample size,and age range. 
Limitations of the study. This study was based ,on 
intermediate-duration recordings, which yield different values 
for SDNN than shorter or longer recordings. The recordings 
JAW Vol. 3, No. h TWJI ET AL. 
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Table 4. Percentile Values of Heart Rate Variahilit Measures Predicted for Specified Ages and Heart Rates in “Hcalth~” Subjeas’ 
Percentile 
HRV Mrasurc 
HR 
ibcatsmin) Slit 5Oth 5th 
- 
S(hh 5th 
VLFt 
LF 
HF 
TPf 
LFIHF 
2-h SDNN 
PNNM 
K-MSSD 
424u h.XS x.:x1 :.r11s 
I,)ulc ?.7;lh 3,s71 I.IW 
MN I Ixh I.554 4% 
I .4x$ I.4M 3,537 71s 
734 1.33 1.67 3x3 
424 XH 1 .Iw)7 N4 
373 7.2 1,143 1X4 
IF1 351 556 89 
t;H 171 270 43 
b.621 9,932 I?.lh') 3.7h.l 
3.074 4.hl I h.l I4 1.747 
1.42: 2.141 2,NW s11 
I.42 2.25 3.w I .3Y 
I .Sh ‘.4? 3.4U 1.53 
1.71 2.71 3.73 I.hn 
113 I4n 1h4 91 
80 w Ilh 6s 
56 M 8’ . 46 
13 32 61 5 
3 H lb 1 
1 2 4 c. 1 
40 Sb 70 31 
24 41 43 i4 
1s ?I ?h II 
Z.shl 
Lhta 
?:I 
l.iQb 
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‘Values were generated kom a subset of subjects who were free of clinically apparent coronary heart discax, ccrehrovascular disease. con@ve hear! failurr and 
diabetes. and who were no1 reaiving urdioxtive medicationr Linear regression. adjusting fnr age and heart rate. was used with nrlural Iq-Irandomed data Dr heart 
rate variability (HRV) measures. Estimates 65th. 2SSth and .((hh percentile values were made by applying normal rhcoryro Ihc residuals of Ihr natural log-tramformed 
data hefore transforming hack tn the original units. tBased on a I(Y)-s sampling method. Otl-cr abbrcvialion, ah :n Tahlr I. 
were obtained while subjects underwent an extensive clinic 
evaluation and are not representative of basal rest conditions. 
Frequency domain measures were obtained using a 100-s 
sampling method, which results in a lowest frequency response 
of 0.01 Hz. Last, the formulas for predicting normative refer- 
ence values were ob!ained in subjects 20 to 79 years old with a 
heart rate of 40 to 99 beats/min and should not be extrapolated 
to values of age or heart rate outside these ranges. 
Comdusioas. There are many clinical variables associated 
with reduced or increased heart rate variability. The impact of 
age and heart rate must be taken into account when evaluating 
heart rate variability. 
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